Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Additional filters

Article Language

Species

Sex

Age

Other

Search Results

356 results

Filters applied: . Clear all
Results are displayed in a computed author sort order. The Publication Date timeline is not available.
Page 1
Protease sequences from HIV-1 group M subtypes A-H reveal distinct amino acid mutation patterns associated with protease resistance in protease inhibitor-naive individuals worldwide. HIV Variant Working Group.
Pieniazek D, Rayfield M, Hu DJ, Nkengasong J, Wiktor SZ, Downing R, Biryahwaho B, Mastro T, Tanuri A, Soriano V, Lal R, Dondero T. Pieniazek D, et al. Among authors: downing r. AIDS. 2000 Jul 28;14(11):1489-95. doi: 10.1097/00002030-200007280-00004. AIDS. 2000. PMID: 10983635
Detection of phylogenetically diverse human immunodeficiency virus type 1 groups M and O from plasma by using highly sensitive and specific generic primers.
Yang C, Pieniazek D, Owen SM, Fridlund C, Nkengasong J, Mastro TD, Rayfield MA, Downing R, Biryawaho B, Tanuri A, Zekeng L, van der Groen G, Gao F, Lal RB. Yang C, et al. Among authors: downing r. J Clin Microbiol. 1999 Aug;37(8):2581-6. doi: 10.1128/JCM.37.8.2581-2586.1999. J Clin Microbiol. 1999. PMID: 10405405 Free PMC article.
Analysis of genetic variability within the immunodominant epitopes of envelope gp41 from human immunodeficiency virus type 1 (HIV-1) group M and its impact on HIV-1 antibody detection.
Dorn J, Masciotra S, Yang C, Downing R, Biryahwaho B, Mastro TD, Nkengasong J, Pieniazek D, Rayfield MA, Hu DJ, Lal RB. Dorn J, et al. Among authors: downing r. J Clin Microbiol. 2000 Feb;38(2):773-80. doi: 10.1128/JCM.38.2.773-780.2000. J Clin Microbiol. 2000. PMID: 10655384 Free PMC article.
Predominance of HIV-1 subtype A and D infections in Uganda.
Hu DJ, Baggs J, Downing RG, Pieniazek D, Dorn J, Fridlund C, Biryahwaho B, Sempala SD, Rayfield MA, Dondero TJ, Lal R. Hu DJ, et al. Among authors: downing rg. Emerg Infect Dis. 2000 Nov-Dec;6(6):609-15. doi: 10.3201/eid0606.000609. Emerg Infect Dis. 2000. PMID: 11076719 Free PMC article.
Resistance to antiretroviral therapy among patients in Uganda.
Weidle PJ, Kityo CM, Mugyenyi P, Downing R, Kebba A, Pieniazek D, Respess R, Hertogs K, De Vroey V, Dehertogh P, Bloor S, Larder B, Lackritz E. Weidle PJ, et al. Among authors: downing r. J Acquir Immune Defic Syndr. 2001 Apr 15;26(5):495-500. doi: 10.1097/00126334-200104150-00017. J Acquir Immune Defic Syndr. 2001. PMID: 11391172
No evidence for HIV-2 infection in Uganda.
Downing RG, Biryahwaho B. Downing RG, et al. Lancet. 1990 Dec 15;336(8729):1514-5. doi: 10.1016/0140-6736(90)93227-g. Lancet. 1990. PMID: 1979128 No abstract available.
356 results